IGF-1
Selected indexed studies
- IGF-1 and cardiovascular disease. (Growth Horm IGF Res, 2019) [PMID:30735831]
- Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. (Int J Mol Sci, 2021) [PMID:34208601]
- IGF-1 and IGFBP-3 in Inflammatory Cachexia. (Int J Mol Sci, 2021) [PMID:34502376]
_Worker-drafted node — pending editorial review._
Connections
IGF-1 is a risk factor for
Sources
- IGF-1 and cardiovascular disease. (2019) pubmed
- Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. (2021) pubmed
- IGF-1 and IGFBP-3 in Inflammatory Cachexia. (2021) pubmed
- The IGF-1 Signaling Pathway in Viral Infections. (2021) pubmed
- The AR/miR-221/IGF-1 pathway mediates the pathogenesis of androgenetic alopecia. (2023) pubmed
- Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. (2020) pubmed
- When IGF-1 Meets Metabolic Inflammation and Polycystic Ovary Syndrome. (2024) pubmed
- Gut Microbiota and IGF-1. (2018) pubmed
- Implications of the PAPP-A-IGFBP-IGF-1 pathway in the pathogenesis and treatment of polycystic kidney disease. (2020) pubmed
- IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development. (2017) pubmed